1Conbination Therapy of Radiation, Hyperthermia and Inta-Arterial Carboplatin for Locally Recurrent Cervical Cancer
Tsuda H, Tanaka M, Manabe T, Hashiguchi Y, Nishimura S, KawamuraK, Nakata S, Yamamoto K
2003The 34th annual meeting of Society of Gynecologic OncologistNew Orleans
2Randomized phase III trial of conventional paclitaxel and carboplatin （c-TC） versus dose dense weekly paclitaxel and carboplatin （dd-TC） in women with advanced epithelial ovarian, fallopian tube, or primary peritoneal cancer Japanese Gynecologic Oncology
Isonishi S, Yasuda M, Takahashi F, Katsumata N, Kimura E, Aoki D, Jobo T, Terauchi H, Tsuda H, Sugiyama T
2008The 44th annual meeting of American Society of Clinical OncologyChicago
3Analysis of unsuccessful outcome cases among 165 young patients with endometrial cancer who received fertility-preserving hormonal therapy using medroxyprogesteron acetate
Susumu N, Yamagami W, Ichikawa Y, Nomura H, Kataoka F, Hirasawa A, Tominaga E, Suzuki A, Banno K, Tsuda H, Aoki D
2012The 14th Biennial Meeting International Gynecologic Cancer Society （IGCS） Plenary sessionVancouver
Poster discussion session
1Genomic and Expression Analysis of Microdissected Ovarian Clear Cell Adenocarcinoma Using an Ovarian Specific cDNA Microarray
Tsuda H, Birrer MJ, Ito YM, Ohashi Y, Wong KK, Lau CC, Gardner G, Hashiguchi Y, Berkowitz RS, Mok SC
2003The 39th annual meeting of American Society of Clinical OncologyChicago
2Comparison of cyclin expression between endometrioid-type endometrial cancer （EEC） and endometrioid ovarian cancer （EOC）
Nishimura S, Tsuda H, Hashiguchi Y, Garner EIO, Inoue T, Kawamura N, Mok SC
2004The 40th annual meeting of American Society of Clinical OncologyNew Orleans
3Photodynamic therapy for cervical intraepitherial neoplasia
Yamaguchi S, Tsuda H, Takemori M, Nishimura S, Kawamura N, Nishimura R
2004The 40th annual meeting of American Society of Clinical OncologyNew Orleans
General Poster session
1Endometrial thickness as measured by transvaginal ultrasonography for identifying endometrial malignancy in postmenopausal women
Tsuda H, Kawabata M, Kawabata K, Yamamoto K, Hidaka A
1994The 75th WFUMBSapporo
2The p16-Cyslin D1／CDK4-pRb pathway and clinical outcome in epithelial ovarian cancer
Tsuda H, Kusume T, Kawabata M, Inoue T, Yamamoto K
1999The 35th annual meeting of American Society of Clinical OncologyAtlanta
3Correlation between the abnormality of G1 pathway and status of estrogen receptor in endometrioid-type endometrial carcinoma
Tsuda H, Kawabata M, Inoue T, Yamamoto K
2000The 36th annual meeting of American Society of Clinical OncologyNew Orleans
4Relationships between HPV typing and abnormality of G1 pathway in cervical neoplasm
Hashiguchi Y, Tsuda H, Inoue T, Yamamoto K, Ogita S
2001The 37th annual meeting of American Society of Clinical OncologySan Francisco
5Phase I-II study of neoadjuvant chemoradiotherapy （NACR） followed by radical surgery in locally advanced cervical cancer（LACC）
Motohisa C, Tsuda H, Tanaka M, Manabe T, Nakata S, Yamamoto K
2001The 37th annual meeting of American Society of Clinical OncologySan Francisco
6The abnormality of cell cycle regulators and clinical outcome in epithelial ovarian cancer （EOC）
Hashiguchi Y, Tsuda H, Inoue T, Yamamoto K, Suzuki T
2002The 38th annual meeting of American Society of Clinical OncologyOrland
7Abnormality of G2 pathway during carcinogenesis of endometrium
Hashiguchi Y, Tsuda H, Inoue T, Yamamoto K
2002The27th annual meeting of European Society of Medical OncologyNice
8Photodynamic Therapy for Cervical Intraepitherial Neoplasia
Nishimura S, Tsuda H, Nakata S, Miyama M, Kawamura N, Hashiguchi Y, Yamamoto K
2003The 34th annual meeting of Society of Gynecologic OncologistNew Orleans
9Relationships between HPV typing and abnormality of G2 pathway in cervical neoplasm
Hashiguchi Y, Inoue T, Tsuda H, Kawamura N
2003The 39th annual meeting of American Society of Clinical OncologyChicago
10Endometrial assessment in Japanese postmenopausal women with high risk factors of endometrial cancer by transvaginal ultrasound
Nishimura S, Tsuda H, Nakamura H, Kawamura N, Hosoi M, Satoh T, Fujii S
2004The 35th annual meeting of Society of Gynecologic OncologistSan Diego
11Genomic and Expression Analysis of Microdissected Ovarian Clear Cell Adenocarcinoma Using an Ovarian Specific cDNA Microarray
Tsuda H, Birrer MJ, Ito YM, Ohashi Y, Wong KK, Lau CC, Hashiguchi Y, Berkowitz RS, Mok SC
2004The 35th annual meeting of Society of Gynecologic OncologistSan Diego
12Phase I-II study of irinotecan and nedaplatin with recombinant human granulocyte colony stimulating factor support in patients with advanced and recurrent cervical cancer
Tsuda H, Hashiguchi Y, Nishimura S, Miyama M, Nakata S, Negoro S, Kawamura N
2004The 40th annual meeting of American Society of Clinical OncologyNew Orleans
13Prognostic value of ABCF2 in ovarian clear cell adenocarcinoma
Tsuda H, Ito YM, ItoK, Yaegashi N, Nishimura S, Birrer MJ ,Ohashi Y, Hashiguchi Y, Berkowitz RS, Mok SC
2005The 41th annual meeting of American Society of Clinical OncologyOrland
14ABCF2 is a new biomarker of ovarian clear cell adenocarcinoma
Nishimura S, Ito YM, ItoK, Yaegashi N, Tsuda H, Birrer MJ, Ohashi Y, Hashiguchi Y, Berkowitz RS, Mok SC
2005The 41th annual meeting of American Society of Clinical OncologyOrland
15ABCF2 expression in endometrial cancer and breast cancer
Tsuda H, Ogawa Y, Nishimura S, Kajitani K, Hashiguchi Y, Kawamura N, Berkowitz RS, Mok SC
2006The 42th annual meeting of American Society of Clinical OncologyAtlanta
16ABCF2 expression may predict the prognosis of cervical cancer
Nishimura S, Tsuda H, Kajitani K, Hashiguchi Y, Kawamura N, Berkowitz RS, Mok SC
2006The 42th annual meeting of American Society of Clinical OncologyAtlanta
17ABCF2 expression in uterine cancer
Tsuda H, Nishimura S, Kajitani K, Sudo T, Hashiguchi Y, Kawamura N, Berkowitz RS, Mok SC
2006The 11th biannual meeting of International Gynecologic Cancer SocietySanta Monica
18Association of genetic variants of UDP-glucuronosyltransferase 1A1 gene with rum bilirubin level in the Japanese
Hirasawa A, Tsuruta T, Nomura H, Kataoka F, Tominaga E, Banno K, Suzuki A, Tsuda H, Naganishi H, Saito K, Zama T, Tanigawara Y, Susumu N, Aoki D
2008International Conference on PharamacogenomicsBusan
19Development of peritoneal dissemination of ovarian clear cell adenocarcinoma can vary with sialidase expression
Nomura H, Kataoka F, Tsuda H, Tamada Y, Suzuki A, Susumu N, Aoki D
2008ICHCGdansk
20Outcome of fertility-preserving mpa therapy for young patients with atypical endometrial hyperplasia complex or different grades of endometrial cancer
Susumu N, Hirasawa A, Ichikawa Y, Suemori T, Kobayashi Y, Nomura H, Kataoka F, Tominaga E, Suzuki A, Tsuda H, Banno K, Aoki D
2008The 12th Biennial Meeting International Gynecologic Cancer Society （IGCS）Bangkok
21Lymph node metastasis in glossly stage I and II epithelial ovarian cancer
Nomura T, Tsuda H, kataoka F, Chiyoda T, Hirasawa A, Tominaga E, Suzuki A, Susumu N, Aoki D
2009The 16th ESGOBelgrade
22Fertility-preserving high-dose medroxyprogesterone acetate （MPA） therapy for 4 young patients with grade 2 endometrial adenocarcinoma
Susumu N, Hirasawa A, Yamagami YW, Kisu I, Ueki A, Kobayashi Y, Tsuruta T, Nomura H, Kataoka F, Suzuki A, Banno K, Tsuda H, Aoki D
2010The 13th biannual meeting of International Gynecologic Cancer SocietyPrague
23Effects of third-line chemotherapy for women with recurrent ovarian cancer who received platinum ／ taxane regimens as first-line chemotherapy
Yoshihama T, Chiyoda T Tsuda H, Nomura H, Kataoka F, Tominaga E, Yamagami W, Iguchi Y, Hashimoto S, Susumu N, Shiraishi S, Aoki D
2012The 14th Biennial Meeting International Gynecologic Cancer Society （IGCS）Vancouver
24A gene expression profile as a predictor of recurrence in low and intermediate-risk endometrial cancer
Chiyoda T, Tsuda H, Ito YM, Tanaka H, Takano M, Nishimura S, Kataoka F, Nomura H, Hirasawa A, Susumu N, Aoki D
2012The 14th Biennial Meeting International Gynecologic Cancer Society （IGCS）Vancouver
25Classification of epithelial ovarian cancer based on the stromal gene expression related with recurrence of endometrial cancer
Iguchi Y, Tsuda H, ito YM, Kataoka F, Tanaka H, Nomura H, Chiyoda T, Hirasawa A, Tominaga E, Yamagami W, Susumu N, Aoki D
2012The 14th Biennial Meeting International Gynecologic Cancer Society （IGCS）Vancouver
26Review of cases of ovarian borderline tumors with tumor-derived atypical cells in peritoneal cytology
Iguchi Y, Kataoka F, Nomura H, Tsuda H, Chyoda T, Hashimoto S, Takigawa A, Kuwahata M, Yamagami W, Tominaga E, Susumu N, Aoki D
201318th International Congress of CytologyParis
27Measurement of endometrial thickness in premenopausal women in office geyencology - MET study –
